Cencora, Inc. (COR)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Cencora, Inc. (COR)
Company Performance

Current Price

as of Dec 02, 2024

$249.87

P/E Ratio

33.16

Market Cap

$48.29B

Description

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment focuses on the distribution of specialty, brand-name, and generic pharmaceuticals. The International Healthcare Solutions segment includes pharmaceutical wholesale, related operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Metrics

Overview

  • HQConshohocken, PA
  • SectorDistribution Services
  • IndustryMedical Distributors
  • TickerCOR
  • Price$249.87-0.67%

Trading Information

  • Market cap$48.29B
  • Float89.47%
  • Average Daily Volume (1m)1,261,988
  • Average Daily Volume (3m)1,475,148
  • EPS$7.60

Company

  • Revenue$293.96B
  • Rev growth (1yr)12.12%
  • Net income$1.51B
  • Gross margin2.96%
  • EBITDA margin1.41%
  • EBITDA$4.15B
  • EV$47.61B
  • EV/Revenue0.16
  • P/E33.16
  • P/S0.17
  • P/B75.41
Documents
SEC Filings
8-K (2024-11-27)
8-K (2024-11-08)
8-K (2024-11-06)
8-K (2024-10-15)
8-K (2024-09-05)
8-K (2024-08-16)
8-K (2024-08-15)
8-K (2024-08-05)
8-K (2024-07-31)
8-K (2024-05-24)
8-K (2024-05-03)
8-K (2024-05-01)
8-K (2024-04-23)
8-K (2024-03-15)
8-K (2024-03-12)
8-K (2024-02-27)
8-K (2024-02-09)
8-K (2024-02-07)
8-K (2024-01-31)
8-K (2024-01-16)
8-K (2023-12-26)
8-K (2023-12-21)
8-K (2023-11-14)
8-K (2023-11-02)
8-K (2023-10-10)
8-K (2023-08-30)
8-K (2023-08-15)
8-K (2023-08-08)
8-K (2023-08-02)
8-K (2023-06-20)
8-K (2023-06-09)
8-K (2023-05-15)
8-K (2023-05-05)
8-K (2023-05-02)
8-K (2023-04-20)
8-K (2023-03-15)
8-K (2023-02-01)
8-K (2023-01-26)
8-K (2023-01-24)
8-K (2023-01-03)
10-Q (2024-07-31)
10-Q (2024-05-01)
10-Q (2024-01-31)
10-Q (2023-08-02)
10-Q (2023-05-02)
10-Q (2023-02-01)
10-K (2024-11-26)
10-K (2023-11-21)
Wikipedia
Cencora_Inc.
Factset Street Account
StreetAccount Metrics Recap - Cencora Q4 Earnings ($187.23, 0.00) (2023-11-02T10:37:09Z)
StreetAccount Earnings Call Q&A Summary: Cencora Q4 ($ 185.08, -2.15) (2023-11-02T14:16:36Z)
StreetAccount Consensus Metrics Preview - Cencora Q4 Earnings ($185.44, -2.20) (2023-10-30T17:02:27Z)
Insider transaction: Cencora Executive Vice President Silvana Battaglia discloses sale of 14.7K shares - Form 4 ($195.00, 0.00) (2023-11-17T21:30:58Z)
Cencora reports Q4 EPS $2.86 ex-items vs FactSet $2.81 [13 est, $2.77-2.90] ($187.23, 0.00) (2023-11-02T10:34:50Z)
Earnings Calls
Earnings Report 2024Q4
Earnings Report 2024Q3
Earnings Report 2024Q2
Earnings Report 2023Q3
Earnings Report (2023-08-02)
Factset
Factset Business Description